GT BIOPHARMA, INC. Interest Payable, Current
GT BIOPHARMA, INC. (GTBP) had Interest Payable, Current of $0 as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2022-03-28
- 2021-09-30: Interest Payable, Current $0.00.
- 2021-06-30: Interest Payable, Current $0.00.
- 2021-03-31: Interest Payable, Current $0.00.
- 2020-12-31: Interest Payable, Current $4.84M.
| Period end | Interest Payable, Current |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q/A · filed 2021-12-29 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 |
| 2020-12-31 | $4.84M 10-K · filed 2022-03-28 |
| 2020-09-30 | $4.18M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $3.28M 10-Q/A · filed 2020-08-18 |
| 2020-03-31 | $2.65M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.03M 10-K · filed 2021-04-16 |
| 2019-09-30 | $1.46M 10-Q · filed 2019-11-14 |
| 2018-12-31 | $432.00K 10-K · filed 2020-03-27 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 |
| 2017-06-30 | $4.34M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $3.87M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $3.80M 10-K · filed 2018-03-01 |
| 2016-09-30 | $3.48M 10-Q/A · filed 2018-02-28 |
| 2016-06-30 | $2.85M 10-Q/A · filed 2018-02-28 |
| 2016-03-31 | $2.75M 10-Q/A · filed 2018-02-28 |
| 2015-12-31 | $2.39M 10-K/A · filed 2018-02-28 |
| 2015-09-30 | $2.61M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $2.51M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $2.18M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $2.02M 10-K/A · filed 2018-02-28 |
| 2014-09-30 | $1.97M 10-Q · filed 2015-01-08 |
| 2014-06-30 | $1.79M 10-Q · filed 2015-01-08 |
| 2014-03-31 | $1.70M 10-Q · filed 2015-01-08 |
| 2013-12-31 | $1.62M 10-K · filed 2015-03-31 |
| 2013-09-30 | $1.54M 10-Q · filed 2014-12-17 |
| 2013-06-30 | $1.43M 10-Q · filed 2014-12-12 |
| 2013-03-31 | $1.34M 10-Q · filed 2014-12-10 |
| 2012-12-31 | $1.25M 10-K · filed 2015-01-08 |
| 2012-09-30 | $1.23M 10-Q · filed 2012-11-21 |
| 2012-06-30 | $1.16M 10-Q/A · filed 2012-09-13 |
| 2012-03-31 | $1.44M 10-Q · filed 2012-05-21 |
| 2011-12-31 | $1.60M 10-K · filed 2014-11-18 |
| 2011-09-30 | $1.61M 10-Q · filed 2011-11-21 |
| 2011-06-30 | $1.56M 10-Q/A · filed 2011-09-12 |
| 2010-12-31 | $1.44M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |